Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - mitu müeloomit - antineoplastilised ained - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Estonia - Kiestonia - Ravimiamet

ideal trade links uab - tsetirisiin - õhukese polümeerikattega tablett - 10mg 10tk; 10mg 30tk

Estonia - Kiestonia - Ravimiamet

ideal trade links uab - tsetirisiin - õhukese polümeerikattega tablett - 10mg 10tk; 10mg 30tk; 10mg 20tk

Estonia - Kiestonia - Ravimiamet

ideal trade links uab - tsetirisiin - õhukese polümeerikattega tablett - 10mg 20tk; 10mg 50tk; 10mg 10tk; 10mg 100tk

Estonia - Kiestonia - Ravimiamet

pxg pharma gmbh - tsetirisiin - õhukese polümeerikattega tablett - 10mg 21tk; 10mg 60tk; 10mg 90tk; 10mg 14tk; 10mg 50tk; 10mg 45tk; 10mg 1tk; 10mg 30tk; 10mg 10tk; 10mg 100tk; 10mg 20tk

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

camurus ab - buprenorfiini - opioidiga seotud häired - muud närvisüsteemi ravimid - opioidisõltuvuse ravi, mille raames meditsiinilise, sotsiaalse ja psühholoogilise ravi. ravi on mõeldud kasutamiseks täiskasvanutel ja noorukitel vanuses 16 aastat või üle.